论文部分内容阅读
目的探讨小儿支气管肺炎应用布地奈德联合盐酸氨溴索雾化吸入治疗的临床疗效。方法选择2014年1月至2015年1月在临颍县人民医院儿科治疗的48例小儿支气管肺炎患者为研究对象,随机将其分为治疗组与对照组,每组24例。两组患者均采取消炎等对症治疗,在此基础上对照组采取氨溴索雾化吸入,治疗组应用氨溴索联合布地奈德雾化吸入,均以7 d为1个疗程,1个疗程后比较两组患者的临床疗效。结果治疗组发热、咳嗽、气促、啰音、肺部X线阴影持续时间均明显低于对照组(P<0.01),两组患者都未出现明显的不良反应。结论布地奈德联合盐酸氨溴索雾化吸入可明显改善小儿支气管肺炎的临床症状及持续时间,未见明显不良反应,可在临床中推广应用。
Objective To investigate the clinical efficacy of budesonide combined with ambroxol hydrochloride inhalation in children with bronchopneumonia. Methods From January 2014 to January 2015, 48 cases of children with bronchopneumonia treated with pediatric treatment in Linying People’s Hospital were randomly divided into treatment group and control group, with 24 cases in each group. Two groups of patients were taken anti-inflammatory symptomatic treatment, on the basis of the control group to take ambroxol inhalation, the treatment group with ambroxol budesonide inhalation, were 7 d for a course of treatment, a course of treatment After comparing the clinical efficacy of two groups of patients. Results The duration of fever, cough, shortness of breath, auscultation and pulmonary X-ray shadow in the treatment group were significantly lower than those in the control group (P <0.01). No significant adverse reactions occurred in both groups. Conclusions Budesonide combined with inhalation of ambroxol hydrochloride can significantly improve the clinical symptoms and duration of bronchial pneumonia in children, no obvious adverse reactions, which can be widely applied in clinic.